Analysing NHS prescribing costs for asthma

View profile for Mark Levy

General Practitioner with expertise in asthma and experience as expert witness in asthma deaths- available for consultancy on systems for reducing unscheduled asthma care

Prescribing costs are analysed by NHS managers in isolation of associated healthcare costs. So GPs are incentivised to prescribe cheaply. In asthma where short acting beta-2- bronchodilators (SABAs) are prescribed in excess, and at risk for patients, the costs increase exponentially with increased numbers of these SABAs per year. We analysed the costs in two published papers and present them in an easy to understand infographic- hopefully health care managers will now actively discourage excess SABAs and favour Inhaled Corticosteroids for all people with asthma - either as needed with formoterol or as part of a MART regime as per www.ginasthma.org. Asthma: effect of excess short-acting β2-agonist (SABA) inhaler prescriptions on healthcare resource utilisation https://lnkd.in/eZ6cAPsj

Andrew Roberts

Experienced Pharmaceutical Professional

7mo

That’s a fabulous opening statement that explains decades of ineffective prescribing in many treatment areas. Given policy makers now seem to accept that the NHS is broken and largely through ill thought through management policies, let’s give clinicians greater control and responsibility for budget and policy and we may just see budget allocations align with outcomes.

Like
Reply
Glenis Scadding

Vice President and lead for Allergic Rhinitis, EUFOREA

7mo

The NHS fails to consder lifetime costs of treatment of asthma when it disallows preventive treatment such as sublingual immuntherapy in predisposed allergic children

Sandra-Jane Stock

HCA (Paediatrics) at NNUH

7mo

It would also help if all the costs were seen at point of prescribing e.g. more than 6 SABAs in a year for a child = how many acute attendances at secondary care & potentially PICU admissions or worse as you & others have pointed out over many years & the NRAD report still being largely ignored

Like
Reply
Sarah Sinton

Practice Nurse at Surgery

7mo

I work in primary care a totally agree with this. Often repeats are managed by reception staff who do not have the knowledge or understanding of the medication when clicking issue and often ignor issue limits.

Like
Reply

Poorly controlled asthma is expensive. It is costly in terms of quality of life, productivity, relationships and achievement to the patient and society and in unplanned attendances at GP surgeries and A&E. And what price do you put on an avoidable asthma death

Like
Reply
Susan Kelly

Innovate UK awards x3 CEO Respiratory Analytics aflo uses sensor tech and deep data analytics to automate correct inhaler technique for better self management, reduced carbon, prediction & remote monitoring in asthma

7mo

A very useful infographic, thank you for sharing Mark Levy

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics